Wockhardt Q1 net profit falls 94 pc on plant bans

Tags: Companies
Generic drugmaker Wockhardt Ltd on Tuesday said its quarterly net profit plunged 94 percent, as US Food and Drug Administration bans on its manufacturing plants continued to take a toll.

Wockhardt's April-June net profit was 199.5 million rupees($3.26 million), compared with 3.23 billion rupees a year earlier.

Net sales slumped 27 percent to 9.91 billion rupees.

The United States is Wockhardt's biggest market and the FDA has banned the import of generic drugs from two of the company's plants in India, citing quality lapses in the manufacturing process.

In May, the company said the FDA had also expressed concerns over production processes at its Chicago-based Morton Grove Pharmaceuticals unit, which accounts for more than 50 percent of Wockhardt's sales in the United States.

Wockhardt shares fell 5 percent to 674 rupees by 0627 GMT on Nifty that was up 0.54 percent.

EDITORIAL OF THE DAY

  • A sexist construction of women denies the man the chance of being a man, fully

    Salman Khan’s recent remark comparing what he felt when he walked out of the wrestling ring in his film Sultan with “a raped woman walking out”

FC NEWSLETTER

Stay informed on our latest news!

TODAY'S COLUMNS

Tushar Gandhi

The shame of rejecting our women

Recently, three young women broke into the elite male basti­on ...

Kuruvilla Pandikattu

Free food operation for the needy

Food is obviously a basic necessity. Recently a nob­le ...

Shona Adhikari

How Brexit will affect the world of art

The results of UK’s exit vote has led to a ...